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Edited by Judit Ova´diAbstract The 2-C-methyl-D-erythritol 4-phosphate pathway
has been proposed as a promising target to develop new antimi-
crobial agents. However, spontaneous mutations in Escherichia
coli were observed to rescue the otherwise lethal loss of the ﬁrst
two enzymes of the pathway, 1-deoxy-D-xylulose 5-phosphate
(DXP) synthase (DXS) and DXP reductoisomerase (DXR), with
a relatively high frequency. A mutation in the gene encoding the
E1 subunit of the pyruvate dehydrogenase complex was shown to
be suﬃcient to rescue the lack of DXS but not DXR in vivo, sug-
gesting that the mutant enzyme likely allows the synthesis of
DXP or an alternative substrate for DXR.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Isoprenoids are an astonishingly diverse group of com-
pounds synthesized in all living organisms [1,2]. Isoprenoids
play essential roles in membrane structure (sterols and hopa-
noids), redox reactions (side chain of ubiquinone, menaquin-
one, plastoquinone and phylloquinone), light harvesting and
photoprotection (carotenoids and side chain of chlorophylls)
and regulation of growth and development (hormones and
substrates for protein modiﬁcation). Despite their diversity
of functions and structures all isoprenoids derive from the
ﬁve-carbon building units isopentenyl diphosphate (IPP) and
its isomer dimethylallyl diphosphate (DMAPP). There are
two pathways for the synthesis of IPP and DMAPP, the mev-
alonic acid (MVA) pathway and the recently elucidated 2-C-
methyl-D-erythritol 4-phosphate (MEP) pathway [3–5]. Most
living organisms have a single pathway for the synthesis of iso-
prenoid building units. Thus, archaebacteria, fungi and ani-Abbreviations: DXP, 1-deoxy-D-xylulose 5-phosphate; DXR, DXP
reductoisomerase; DXS, DXP synthase; MEP, 2-C-methyl-D-erythritol
4-phosphate; MVA, mevalonic acid; PDH, E1 subunit of the pyruvate
dehydrogenase complex
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operation of the MVA pathway, whereas the MEP pathway
is the only one present in most eubacteria (including Esche-
richia coli and many pathogenic microbia) and apicomplexan
protozoa (such as the malaria parasite Plasmodium falcipa-
rum). Therefore, the MEP pathway has been proposed as a
promising target for the design of new antibacterial and anti-
malarial agents potentially innocuous for humans [6].
The genes and enzymes of the MEP pathway are best char-
acterized in E. coli (reviewed in [3,4]). As shown in Fig. 1, the
initial reaction of the pathway is the formation of 1-deoxy-D-
xylulose 5-phosphate (DXP) from pyruvate and D-glyceralde-
hyde 3-phosphate catalyzed by the enzyme DXP synthase
(DXS). Since DXP is also involved in the biosynthesis of thia-
min (vitamin B1) and pyridoxol (vitamin B6) in E. coli, the
intramolecular rearrangement and reduction of DXP by the
enzyme DXP reductoisomerase (DXR) to form MEP is actu-
ally the ﬁrst committed step of the pathway. The sequential
activities of the enzymes encoded by the genes ispD/ygbP,
ispE/ychB, ispF/ygbP and ispG/gcpE mediate the transforma-
tion of MEP into hydroxymethylbutenyl 4-diphosphate
(HMBPP). In the last step of the pathway, a reductase encoded
by the ispH/lytB gene converts HMBPP into a 5:1 mixture of
IPP and DMAPP. The activity of the IPP/DMAPP isomerase
encoded by the idi gene can intercovert IPP and DMAPP
(Fig. 1).
In the context of the MEP pathway as a new target for anti-
biotic and antimalarial drugs, it is especially relevant to evalu-
ate the possibility of spontaneous mutations that could
suppress the otherwise lethal block of the MEP pathway in liv-
ing bacteria or protozoa. To address this question we have
used E. coli strains harbouring deletions in individual MEP
pathway genes (Fig. 1). We demonstrate that the loss of
DXS or DXR activities can be bypassed at a relatively high
frequency in E. coli and identify one of the mutations that sup-
press the lethal phenotype of DXS-defective cells.2. Materials and methods
2.1. Bacterial strains
A DNA fragment containing a synthetic operon with genes required
for the production of IPP and DMAPP from MVA (MVA+ operon)
cloned between a kanamycin-resistance gene and a promoter-less ver-
sion of the lac operon was stably integrated into the chromosome of
TE2680 cells (with a recD mutation that allows homologous recombi-blished by Elsevier B.V. All rights reserved.
Fig. 1. The MEP pathway in E. coli. GAP, D-glyceraldehyde
3-phosphate; DXP, 1-deoxy-D-xylulose 5-phosphate; MEP, 2-C-
methyl-D-erythritol 4-phosphate; CDP-ME, 4-diphosphocytidil 2-C-
methyl-D-erythritol; CDP-MEP, CDP-ME 2-phosphate; ME-cPP,
2-C-methyl-D-erythritol 2,4-cyclodiphosphate; HMBPP, hydroxym-
ethylbutenyl 4-diphosphate; IPP, isopentenyl diphosphate; DMAPP,
dimethylallyl diphosphate. The indicated genes encode the following
enzymes: dxs, DXP synthase (DXS); dxr, DXP reductoisomerase
(DXR); ispD/ygbP, CDP-ME synthase (CMS); ispE/ychB, CDP-ME
kinase (CMK); ispF/ygbB, ME-cPP synthase (MCS); ispG/gcpE,
HMBPP synthase (HDS); ispH/lytB, HMBPP reductase (HDR); idi,
IPP/DMAPP isomerase (IDI). The E. coli strain used in this work was
engineered to utilize exogenously supplied mevalonic acid (MVA) for
the synthesis of IPP and DMAPP (dotted line).
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create strain EcAB3-1 as described [7]. Disruption of the MEP path-
way genes dxs, dxr, ygbP, ychB, ygbB and gcpE was carried out in
EcAB3-1 cells (in which the presence of the MVA+ operon allowed sur-
vival of the mutants in MVA-supplemented media) by using constructs
in which most of the coding region of the target genes had been substi-
tuted by a sequence encoding chloramphenicol acetyltransferase (CAT)
as described [7,8]. The MVA+ synthetic operon from strain EcAB3-1
[7] was incorporated into the genome of the K-12 MG1655 wild-type
strain by phage P1 transduction [9] to construct strain EcAB4-1. The
same strategy was used to transduce the generated disruptions of indi-
vidual MEP pathway genes into EcAB4-1 cells to create strains
EcAB4-2 (dxs::CAT), EcAB4-10 (dxr::CAT), EcAB4-7 (ygbP::CAT),
EcAB4-9 (ychB::CAT), EcAB4-8 (ygbB::CAT) and ECAB4-4 (gcpE::
CAT).
2.2. Growth conditions
All strains were grown at 37 C in Luria broth (LB) medium. When
required for selection of individual strains, antibiotics were added to
ﬁnal concentrations of 25 lg/ml kanamycin (Km, to select for the
MVA+ operon), 17 lg/ml chloramphenicol (Cm, to select for the dis-
ruption of the MEP pathway genes) or 100 lg/ml ampicillin (Ap, to se-
lect for recombinant plasmids). When indicated, the growth medium
was supplemented with 1 mM MVA prepared as described [7]. Bacte-
rial growth in liquid media was monitored by measuring optical den-
sity at 600 nm (OD600). When required, the culture was diluted to
enable photometric measurement in the linear range (OD600 =
0.1–0.5).
2.3. Identiﬁcation of suppressor mutants
Cells from each EcAB4 strain were cultured in LB medium contain-
ing Km, Cm and MVA until exponential phase. After cells were pel-
leted and rinsed twice with LB, several batches of ca. 109 cells were
plated on LB medium containing only Km and Cm. Spontaneous mu-
tants that formed a colony in the absence of MVA were conﬁrmed to
carry the corresponding disruptions in the MEP pathway genes with
CAT by PCR.
2.4. Construction and screening of genomic DNA libraries
Genomic DNA from SX5 cells was isolated with the 100G kit (Qia-
gen) and partially digested with Bsp143I (Fermentas). Fragments of 2–
7 kb were gel-puriﬁed using the Qiaquick (Qiagen) system and ligated
into the BamHI site of pBR322 (Gibco-BRL). After transformation of
EcAB4-2 competent cells with the ligation reaction products, transfor-
mants resistant to Km, Cm, and Ap which were able to grow without
MVA were selected. Plasmid DNA was isolated from these colonies
and retransformed into EcAB4-2 cells to conﬁrm that it conferred
the ability to grow in the absence of MVA. Both ends of the insert
in these plasmids were sequenced with the Big Dye v2.0 kit of the
ABI-PRISM system (Applied Biosystems) using vector primers.2.5. Plasmid constructs
The aceE gene and its promoter were ampliﬁed from EcAB4-1 and
SX5 cells by PCR using Pfu DNA polymerase (Promega) and primers
aceE-1F (5 0CCAGAAGATGTTGTAAATCAAGC-3 0) and aceE-4R
(5 0-TTTACCTCTTACGCCAGACG-30). The PCR products were
gel-puriﬁed and cloned into the EcoRV site of plasmid pBR322 to gen-
erate constructs pBR-Pr-aceE and pBR-Pr-aceE\, respectively. Inserts
were sequenced using vector and gene-speciﬁc primers to conﬁrm that
the nucleotide at position 1909 in the aceE gene was G in pBR-Pr-aceE
(wild-type) and C (E636Q mutant) in pBR-Pr-aceE\.3. Results
3.1. Spontaneous mutations suppress the lethal phenotype caused
by loss of DXS or DXR activity in E. coli
Deletion of individual MEP pathway genes in E. coli strains
harbouring the synthetic MVA+ operon (which allows the syn-
thesis of both IPP and DMAPP from MVA) results in a lethal
phenotype that can be rescued when MVA is exogenously
Fig. 2. Growth kinetics of the E. coli strains generated in this work.
After inoculation of liquid medium without MVA with cells of the
indicated strains grown on medium supplemented with MVA (or not,
when indicated; black circles), growth at 37 C was monitored at the
indicated times by measuring OD600. Mean values and standard errors
from at least three independent cultures are shown.
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could be occasionally suppressed in vivo by spontaneous muta-
tions in at least some of the MEP pathway-defective strains.
To estimate the frequency of such mutations, strains with dis-
rupted MEP pathway genes were plated in the absence of
MVA and the formation of isolated colonies after 48 h at
37 C was recorded. The higher frequency of MVA auxotro-
phy suppression was found for the DXS-deﬁcient strain
EcAB4-2 (6.4 per 109 cells), whereas the DXR-deﬁcient strain
EcAB4-10 showed a slightly lower frequency (2.4 per 109 cells).
In the case of DXS-deﬁcient cells, colonies of suppressor mu-
tants (SX) could be detected overnight. By contrast, rescue
of the lethal phenotype caused by the loss of DXR activity
took longer (48 h). No suppressor mutants were found in
strains with disrupted ygbP, ychB, ygbB or gcpE genes.
Six SX mutants (SX1–6) in which the disruption of the dxs
gene with CAT was conﬁrmed by PCR were rescued. Phage
P1-mediated transduction of parts of their genome to the ori-
ginal EcAB4-2 strain resulted in new strains that were able to
grow in the absence of MVA, conﬁrming that a genomic muta-
tion was responsible for the suppression phenotype of SX cells.
The SX5 strain, which showed the best growth rate on both
solid and liquid media, was selected for further characteriza-
tion.
3.2. A mutation in the aceE gene allows the survival of
DXS-defective cells
To identify the genetic change responsible for the bypass of
DXS activity in SX5 cells, a genomic library was constructed in
pBR322 and used to transform EcAB4-2 cells. Colonies able to
grow without MVA were then selected to isolate the incorpo-
rated plasmid. Sequencing of the inserts from two diﬀerent
plasmids showed that both of them contained a common geno-
mic sequence that included the promoters and coding regions
of pdhR (encoding the regulatory subunit of the pyruvate
dehydrogenase complex) and aceE (encoding the catalytic E1
subunit of the same enzyme, PDH). Complete sequencing of
the inserts revealed a missense mutation in the aceE gene,
resulting in a E636Q change in PDH. Sequencing of both
strands of the genomic copies of aceE from EcAB4-2 and
SX5 strains conﬁrmed that the identiﬁed mutation was only
present in the suppressor mutant.
To conﬁrm whether the E636Q mutant version of PDH was
able to bypass the DXS reaction, plasmids carrying the aceEFig. 3. Complementation of E.coli strains defective in DXS or DXR with
(dxs::CAT) and EcAB4-10 (dxr::CAT) cells were transformed with pBR
chloramphenicol (to select for the CAT-mediated disruption) and ampicillin (t
with MVA as indicated. Plates were incubated at 37 C for the indicated timgene (including its promoter) in its wild-type (pBR-Pr-aceE)
or mutated (pBR-Pr-aceE\) form were constructed and used
to transform EcAB4-2 cells. Only the pBR-Pr-aceE\ plasmid
was able to rescue EcAB4-2 growth in liquid cultures (Fig. 2)
or plates (Fig. 3) not supplemented with MVA. These results
demonstrate that the presence of the E636Q mutation in
PDH is necessary and suﬃcient for this enzyme to allow sur-
vival of DXS-defective cells.
As shown in Fig. 2, the growth of SX5 cells in liquid medium
without MVA is signiﬁcantly slower than that of EcAB4-2 cells
carrying the pBR-Pr-aceE\ plasmid, which have a wild-type
aceE gene in their genome in addition to several copies of
the plasmid-harbored mutant gene. Under the same condi-
tions, EcAB4-2 (pBR-Pr-aceE\) cells showed a growth rate in
the exponential phase very similar to that of EcAB4-1 cells
(with a wild-type DXS enzyme), but the former required a
longer lag period to start dividing. The lag phase was much
shorter when the growth medium was inoculated with cells
that had been already growing in the absence of MVAplasmids encoding wild-type and mutant versions of PDH. EcAB4-2
-Pr-aceE or pBR-Pr-aceE\ and plated on LB medium containing
o select for the plasmid). The medium was supplemented (+) or not ()
es.
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tant role when the activity of the E636Q PDH enzyme replaces
loss of DXS function.
3.3. DXR deﬁciency is not rescued by the mutant PDH enzyme
The bypass of DXS activity by E636Q PDH might result
from the production of DXP, an alternative substrate for
DXR, or a downstream intermediate of the pathway (Fig. 1).
A mutant aceE gene would only rescue DXR deﬁciency in
the last case. However, when the pBR-Pr-aceE and pBR-Pr-
aceE\ plasmids were used to transform the DXR-deﬁcient
strain EcAB4-10, transformants were only recovered in
MVA-containing plates. None of them were able to grow on
plates without MVA (Fig. 3), conﬁrming that the mutant
PDH enzyme does not allow the formation of MEP or any
other downstream intermediate of the MEP pathway. These
results suggest that the rescue of DXS deﬁciency in cells har-
bouring the mutant aceE gene requires an active DXR enzyme
and involves the production of DXP or an alternative sub-
strate for DXR.4. Discussion
In this work we show that spontaneous mutations can sup-
press the lethal phenotype of strains defective in DXS or DXR
and demonstrate that a speciﬁc point mutation in the aceE
gene encoding the catalytic E1 subunit of the pyruvate dehy-
drogenase complex (PDH) is suﬃcient to rescue the deﬁciency
of DXS but not DXR activity in vivo. The pyruvate dehydro-
genase complex (formed by E1, E2 and E3 subunits) plays a
pivotal role in carbohydrate utilization by catalysing the oxi-
dative decarboxylation of pyruvate to acetyl-CoA. Before the
identiﬁcation of DXS as the enzyme responsible for the biosyn-
thesis of DXP, puriﬁed PDH from both E. coli and B. subtilis
was shown to catalyse the formation of 1-deoxy-D-xylulose
(DX) from pyruvate and D-glyceraldehyde in vitro [10,11].
Although DX can not be converted to 2-C-methyl-D-erythritol
by DXR, which is highly speciﬁc for DXP [12], DX can be
phosphorylated to DXP by a xylulokinase recently identiﬁed
in E. coli [13]. Therefore, it could be expected that DX pro-
duced by PDH activity was phosphorylated to DXP and used
as a substrate by DXR in E. coli cells. Our results, however,
demonstrate that the wild-type PDH enzyme is unable to over-
come the lack of DXS activity in vivo, even when present in
several copies (as in cells transformed with the pBR-Pr-aceE
construct). Therefore, it is possible that only the E636Q vari-
ant of PDH could synthesize enough DX to rescue the loss
of DXS activity in bacteria. Alternatively, the mutant PDH
might generate DXP from pyruvate and D-glyceraldehyde 3-
phosphate or another unidentiﬁed substrate, or it might syn-
thesize an alternative substrate of DXR.
Although biochemical assays are necessary to ascertain the
activity of the mutant enzyme, our results provide strong ge-
netic evidence of a key role of residue E636 for PDH activity
in vivo, supporting recent data from in vitro studies. The anal-
ysis of E636A and E636Q mutations generated in the bacterial
PDH enzyme by directed mutagenesis concluded that the E636
residue participates in monomer–monomer interactions, aﬀects
the mobility of some key loops located near the active center,
and protects the active site from undesirable carboligase side
reactions [14]. The E636Q mutant enzyme retained 26% ofthe activity relative to wild-type PDH after reconstitution with
E2 and E3 subunits (35% in the absence of the subcomplex),
indicating that decarboxylation of pyruvate was only modestly
aﬀected by the substitution [14]. The retention of parental
PDH activity in the E636Q mutant enzyme would allow ace-
tyl-CoA formation needed for the tricarboxylic acid cycle in
SX5 cells (which only have the mutant version of the aceE
gene). We are currently analyzing the nature of the suppression
mutations in other strains defective in DXS and DXR activi-
ties to identify other mechanisms besides PDH mutation that
can be developed by bacteria to overcome the lethal block of
the MEP pathway. Based on our results, activities other than
DXS and even DXR should be targeted to minimize the devel-
opment of resistance mechanisms in the context of the MEP
pathway as a new target for antibiotic and antimalarial agents.
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